Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ORPEA

Explore full profile

European leader in integrated long-term care and post-acute care

Puteaux, FranceFounded 1989Health Tech & Medtech
Valuation $1.83B Market cap · 2025
Revenue $6.77B Latest reported FY
EBITDA $1.03B Latest reported FY

About ORPEA

In 1989, French neuropsychiatrist Dr. Jean-Claude Marian founded ORPEA, starting with a single retirement home in France. The vision was to professionalize long-term care for the elderly, a market poised for growth due to an aging population. The business model focused on providing comprehensive medical services and comfortable living environments. This strategy proved successful, and the company began a steady expansion within France. A significant milestone arrived in 2002 when ORPEA went public on the Paris Stock Exchange, providing capital for a much larger ambition. The company embarked on an aggressive international expansion, entering markets like Belgium, Spain, and Italy, often through major acquisitions. This growth was heavily fueled by debt and a real estate strategy that involved buying its facilities, which significantly built up its asset portfolio. The company's trajectory took a dramatic and dark turn in January 2022 with the publication of the book "Les Fossoyeurs" ("The Gravediggers") by investigative journalist Victor Castanet. The book alleged systemic issues, including the rationing of food and adult diapers to maximize profits. The impact was immediate and catastrophic. ORPEA's stock price plummeted, its CEO was dismissed, and the company faced criminal complaints and government investigations. Facing insolvency due to its massive debt, ORPEA underwent a painful and complex restructuring. In a dramatic move, a consortium led by the French state-owned institution Caisse des Dépôts et Consignations (CDC) took control in 2023, effectively saving the company from bankruptcy. To distance itself from the scandal and signal a new beginning, the company officially rebranded as emeis in March 2024, a name derived from the ancient Greek for "us."

Source: Dealroom company data

At a glance

Status
Listed
Founded
1989
Headquarters
Puteaux, France
Listing
IPO 2013
Employees
5,119
Open positions
None listed
Dealroom signal
26.1/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Testing, Verification, medical testing
Investment activity
7 companies, latest Apr 2017
Capital deployed
—
Preferred round
ACQUISITION

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO DEBT✓Debt Nov 2025 $0 — Undisclosed ↗
POST IPO EQUITY✓Other financing Sep 2025 $837M — Farallon Capital Management · SCAPRIM ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowthEBITDAMarginProfitMargin
2026 $6.8B +4.3% $1B 15.2% −$144M -2.1%
2025 $6.5B +4.6% $916M 14.1% −$328M -5.1%
2024 $6.2B +8.4% $763M 12.3% −$453M -7.3%
2023 $5.7B +11% $3.9B 68.4%
2022 $5.1B +8.9% $155M 3%
2021 $4.7B +9.6% $1.1B 23.5%
2020 $4.3B — $1B 23.7%
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

ORPEA website traffic

Latest recorded traffic for ORPEA is 1.4K monthly website visits, up 250% over the last three months. ORPEA's team declined 13.7% over the past year.

Latest monthly visits1.4K 3-month web change+250% 1-year team growth-13.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later8 investors entered at this stage

  • BNP Paribas
  • Crédit Agricole
  • Crédit Mutuel Alliance Fédérale
  • Groupe BPCE
  • La Banque Postale
  • Societe Generale
  • Farallon Capital Management
  • SCAPRIM
Team profiled 18 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇫🇷 France · Puteaux HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ORPEA on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ORPEA’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.